Related Articles
Upregulation of JMJD2A promotes migration and invasion in bladder cancer through regulation of SLUG
Jumonji domain containing 2A predicts prognosis and regulates cell growth in lung cancer depending on miR-150
JMJD2A facilitates growth and inhibits apoptosis of cervical cancer cells by downregulating tumor suppressor miR‑491‑5p
IOX1, a JMJD2A inhibitor, suppresses the proliferation and migration of vascular smooth muscle cells induced by angiotensin II by regulating the expression of cell cycle-related proteins
Modulation of intracellular iron metabolism by iron chelation affects chromatin remodeling proteins and corresponding epigenetic modifications in breast cancer cells and increases their sensitivity to chemotherapeutic agents